When the Food and Drug Administration suddenly pulled the Johnson & Johnson coronavirus vaccine from distribution over concerns about very rare blood clotting, many people were worried the FDA’s decision would have a far-reaching effect on the public’s trust in the vaccine. It turns out they were right.

A new poll found that only one in four people not yet immunized against the coronavirus say they would be willing to get the Johnson & Johnson vaccine, and fewer than half of U.S. adults now say they consider the Johnson & Johnson vaccine very or somewhat safe. In comparison, more than seven in 10 people said they regard the Moderna and Pfizer vaccines to be very or somewhat safe.

Recommended Stories

Half of adult population in US has received at least one vaccine dose

Johnson & Johnson says first COVID-19 shots will come within 48 hours

Johnson & Johnson calls its COVID-19 vaccine more effective in US than elsewhere